|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 163.65 INR | -3.78% |
|
-5.45% | +21.72% |
| Apr. 30 | Indian Indices Fall on Thursday as Crude Surge, Global Cues Weigh | MT |
| Apr. 30 | Sun Pharma Advanced to Sell Rare Paediatric Disease Priority Review Voucher for $195 Million | MT |
| Capitalization | 37.28B 389M 334M 306M 292M 534M 543M 3.66B 1.42B 17.69B 1.46B 1.43B 61.65B | P/E ratio 2024 |
-30.9x | P/E ratio 2025 | -14x |
|---|---|---|---|---|---|
| Enterprise value | 39.95B 416M 358M 328M 313M 572M 582M 3.92B 1.52B 18.95B 1.56B 1.53B 66.06B | EV / Sales 2024 |
157x | EV / Sales 2025 | 70.6x |
| Free-Float |
27.04% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Sun Pharma Advanced Research Company Limited
| 1 day | -3.78% | ||
| 1 week | -5.45% | ||
| Current month | +14.41% | ||
| 1 month | +7.31% | ||
| 3 months | +22.41% | ||
| 6 months | +23.91% | ||
| Current year | +21.72% |
| 1 week | 162.01 |  | 175.6 |
| 1 month | 136.72 | | 182.59 |
| Current year | 108 | | 182.59 |
| 1 year | 108 | | 204.4 |
| 3 years | 108 | | 472.8 |
| 5 years | 108 | | 472.8 |
| 10 years | 81 | | 532 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 56 | 2014-04-23 | |
Anup Rathi
DFI | Director of Finance/CFO | - | 2024-06-05 |
| Chief Operating Officer | - | 2024-07-25 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 70 | 2009-11-08 | |
| Director/Board Member | 65 | 2007-06-03 | |
Robert Spiegel
BRD | Director/Board Member | 76 | 2020-05-31 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.78% | -5.45% | +1.83% | -16.06% | 554M | |
| -0.00% | +5.95% | +32.68% | +129.71% | 896B | |
| -1.77% | +2.44% | +49.81% | +42.59% | 546B | |
| -0.18% | +4.39% | +14.33% | +46.77% | 372B | |
| +0.88% | +2.38% | +24.30% | +13.90% | 328B | |
| -0.10% | +2.93% | +27.56% | +28.14% | 283B | |
| -0.79% | +2.16% | +31.97% | +12.94% | 282B | |
| -1.79% | 0.00% | +46.44% | -2.95% | 275B | |
| +0.91% | +3.07% | -29.86% | -47.97% | 206B | |
| -2.22% | -1.62% | +19.79% | +45.01% | 176B | |
| Average | -0.88% | +1.66% | +21.88% | +25.21% | 336.39B | |
| Weighted average by Cap. | -0.50% | +3.38% | +28.74% | +50.61% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 755M 7.87M 6.77M 6.19M 5.91M 10.82M 11.01M 74.16M 28.75M 358M 29.54M 28.91M 1.25B | 718M 7.48M 6.43M 5.88M 5.61M 10.28M 10.46M 70.45M 27.31M 340M 28.06M 27.47M 1.19B |
| Net income | -3.87B -40.36M -34.72M -31.75M -30.29M -55.45M -56.44M -380M -147M -1.84B -151M -148M -6.4B | -3.43B -35.7M -30.71M -28.08M -26.79M -49.05M -49.93M -336M -130M -1.62B -134M -131M -5.66B |
| Net Debt | -960M -10M -8.61M -7.87M -7.51M -13.75M -13.99M -94.23M -36.53M -455M -37.53M -36.73M -1.59B | 2.67B 27.82M 23.94M 21.89M 20.88M 38.23M 38.92M 262M 102M 1.27B 104M 102M 4.41B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-05-15 | 163.65 ₹ | -3.78% | 1,199,582 |
| 26-05-14 | 170.08 ₹ | +0.83% | 1,503,259 |
| 26-05-13 | 168.68 ₹ | +1.35% | 3,024,126 |
| 26-05-12 | 166.43 ₹ | -1.20% | 2,675,178 |
| 26-05-11 | 168.45 ₹ | -2.68% | 2,226,253 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Net sales - Rate of surprise
- Stock Market
- Equities
- SPARC Stock
Select your edition
All financial news and data tailored to specific country editions
